{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:04:41Z","timestamp":1771463081741,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008935","name":"Universit\u00e9 Nice Sophia Antipolis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.atherosclerosis.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T01:57:19Z","timestamp":1581904639000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nuclear receptors in abdominal aortic aneurysms"],"prefix":"10.1016","volume":"297","author":[{"given":"Jaap G.","family":"Neels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9da","family":"Hassen-Khodja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Chinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/CIRCRESAHA.116.308765","article-title":"Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci","volume":"120","author":"Jones","year":"2017","journal-title":"Circ. Res."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2020.02.009_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2010.09.011","article-title":"Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery","volume":"41","author":"Moll","year":"2011","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(14)61005-9","article-title":"Management of acute aortic dissection","volume":"385","author":"Nienaber","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41572-018-0030-7","article-title":"Abdominal aortic aneurysms","volume":"4","author":"Sakalihasan","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/mva.2003.363","article-title":"Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the joint council of the American association for vascular surgery and society for vascular surgery","volume":"37","author":"Brewster","year":"2003","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.82.3.973","article-title":"Elastase-induced experimental aneurysms in rats","volume":"82","author":"Anidjar","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5301\/jva.5000235","article-title":"Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease","volume":"15","author":"Dwivedi","year":"2014","journal-title":"J. Vasc. Access"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archsurg.1984.01390160041009","article-title":"Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms","volume":"119","author":"Dobrin","year":"1984","journal-title":"Arch. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib9","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/ATVBAHA.117.309999","article-title":"TGFbeta (transforming growth factor-beta) blockade induces a human-like disease in a nondissecting mouse model of abdominal aortic aneurysm","volume":"37","author":"Lareyre","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejvs.2016.07.004","article-title":"Animal models used to explore abdominal aortic aneurysms: a systematic review","volume":"52","author":"Lysgaard Poulsen","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jvs.2012.01.038","article-title":"Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model","volume":"56","author":"Yamanouchi","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib12","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000085631.76095.64","article-title":"Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice","volume":"23","author":"Saraff","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib13","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cvr\/cvx128","article-title":"Angiotensin II infusion into ApoE-\/- mice: a model for aortic dissection rather than abdominal aortic aneurysm?","volume":"113","author":"Trachet","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-3724-0_1","article-title":"The nuclear receptor superfamily at thirty","volume":"1443","author":"McEwan","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2012.05.014","article-title":"Nuclear Receptors in atherosclerosis: a superfamily with many 'Goodfellas'","volume":"368","author":"Kurakula","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11883-015-0507-8","article-title":"Nuclear receptors in vascular biology","volume":"17","author":"Bishop-Bailey","year":"2015","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21775\/cimb.022.041","article-title":"Liver X receptors and their agonists: targeting for cholesterol homeostasis and cardiovascular diseases","volume":"22","author":"Ma","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/fca-2016-0059","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-alpha","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-beta\/delta and PPAR-gamma","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCRESAHA.113.301241","article-title":"Vitamin D and cardiovascular disease","volume":"114","author":"Norman","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.10.006","article-title":"The role of androgen receptors in atherosclerosis","volume":"465","author":"Takov","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib23","doi-asserted-by":"crossref","first-page":"T67","DOI":"10.1530\/JOE-17-0009","article-title":"30 years OF the mineralocorticoid receptor: the role of the mineralocorticoid receptor in the vasculature","volume":"234","author":"DuPont","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S2468-1253(17)30246-7","article-title":"Seladelpar (MBX-8025), a selective PPAR-delta agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study","volume":"2","author":"Jones","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113464","article-title":"Elucidating the beneficial role of PPAR agonists in cardiac diseases","volume":"19","author":"Khuchua","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopha.2017.08.083","article-title":"Peroxisome proliferator-activated receptors as therapeutic targets for heart failure","volume":"95","author":"Abushouk","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib28","doi-asserted-by":"crossref","first-page":"H524","DOI":"10.1152\/ajpheart.00217.2016","article-title":"Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease","volume":"313","author":"Boese","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/VHRM.S173259","article-title":"Role of androgens in cardiovascular pathology","volume":"14","author":"Chistiakov","year":"2018","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41440-018-0158-6","article-title":"Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease","volume":"42","author":"Nishiyama","year":"2019","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib31","doi-asserted-by":"crossref","first-page":"1204598","DOI":"10.1155\/2018\/1204598","article-title":"Aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology","volume":"2018","author":"Cannavo","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib32","doi-asserted-by":"crossref","first-page":"110436","DOI":"10.1016\/j.mce.2019.04.016","article-title":"Alternative retinoid X receptor (RXR) ligands","volume":"491","author":"Krezel","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5551\/jat.No786","article-title":"Retinoid X receptor heterodimer variants and cardiovascular risk factors","volume":"16","author":"Nohara","year":"2009","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrcardio.2016.73","article-title":"Vitamin D and cardiovascular disease prevention","volume":"13","author":"Pilz","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib35","doi-asserted-by":"crossref","first-page":"H753","DOI":"10.1152\/ajpheart.00319.2017","article-title":"Vitamin D and regulation of vascular cell function","volume":"314","author":"Jamali","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082307","article-title":"Beyond the foam cell: the role of LXRs in preventing atherogenesis","volume":"19","author":"Rasheed","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-015-0520-7","article-title":"Emerging role of liver X receptors in cardiac pathophysiology and heart failure","volume":"111","author":"Cannon","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jsbmb.2011.01.010","article-title":"NR4All in the vessel wall","volume":"130","author":"van Tiel","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14728222.2017.1279146","article-title":"The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases","volume":"21","author":"Rodriguez-Calvo","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib40","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1194\/jlr.M034157","article-title":"Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice","volume":"54","author":"Chao","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib41","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/stem.1747","article-title":"Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis","volume":"32","author":"Qing","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2009.10.027","article-title":"Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm","volume":"210","author":"Golledge","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2012.04.015","article-title":"Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model","volume":"181","author":"Krishna","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib44","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/1389450119666171227224655","article-title":"Fenofibrate and telmisartan in the management of abdominal aortic aneurysm","volume":"19","author":"Rowbotham","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009866","article-title":"Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME -2 trial","volume":"7","author":"Pinchbeck","year":"2018","journal-title":"J Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-016-1752-z","article-title":"Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial","volume":"18","author":"Rowbotham","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2014.03.138","article-title":"PPARdelta reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses","volume":"174","author":"Hwang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib48","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1161\/CIRCULATIONAHA.109.852467","article-title":"Rosiglitazone reduces the development and rupture of experimental aortic aneurysms","volume":"119","author":"Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib49","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1194\/jlr.M036533","article-title":"CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice","volume":"54","author":"Cai","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib50","first-page":"3421","article-title":"PPARgamma agonist rosiglitazone alters the temporal and spatial distribution of inflammation during abdominal aortic aneurysm formation","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11748-015-0576-1","article-title":"PPAR-gamma agonist attenuates inflammation in aortic aneurysm patients","volume":"63","author":"Motoki","year":"2015","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2265.2009.03615.x","article-title":"Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm","volume":"72","author":"Moran","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib53","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jvs.2010.05.089","article-title":"Vascular smooth muscle cell peroxisome proliferator-activated receptor-gamma deletion promotes abdominal aortic aneurysms","volume":"52","author":"Hamblin","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib54","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/HYPERTENSIONAHA.116.07367","article-title":"Peroxisome proliferator-activated receptor gamma level contributes to structural integrity and component production of elastic fibers in the aorta","volume":"67","author":"Tai","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib55","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41598-019-40322-1","article-title":"Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/aje\/154.3.236","article-title":"Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study : the Tromso Study","volume":"154","author":"Singh","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib57","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/S10016-006-9079-y","article-title":"Gender differences in relative dilatation of abdominal aortic aneurysms","volume":"20","author":"Forbes","year":"2006","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib58","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/bjs.5573","article-title":"Influence of sex on expansion rate of abdominal aortic aneurysms","volume":"94","author":"Mofidi","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib59","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejvs.2013.01.003","article-title":"Gender differences in biomechanical properties, thrombus age, mass fraction and clinical factors of abdominal aortic aneurysms","volume":"45","author":"Tong","year":"2013","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jvs.2017.07.123","article-title":"A registry-based rationale for discrete intervention thresholds for open and endovascular elective abdominal aortic aneurysm repair in female patients","volume":"67","author":"Tomee","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2010.12.049","article-title":"Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database","volume":"54","author":"Egorova","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib62","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1161\/01.ATV.0000143386.26399.84","article-title":"Gender differences in experimental aortic aneurysm formation","volume":"24","author":"Ailawadi","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib63","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib64","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.ATV.0000085842.20866.6A","article-title":"17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice","volume":"23","author":"Martin-McNulty","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib65","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1210\/en.2003-1615","article-title":"Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice","volume":"145","author":"Henriques","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2016.11.005","article-title":"Differential expression of sex hormone receptors in abdominal aortic aneurysms","volume":"96","author":"Villard","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jss.2013.07.050","article-title":"Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males","volume":"186","author":"Laser","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib68","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jvs.2004.09.033","article-title":"Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms","volume":"41","author":"Grigoryants","year":"2005","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib69","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jvs.2015.11.038","article-title":"Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation","volume":"63","author":"Davis","year":"2016","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib70","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/ATVBAHA.107.160382","article-title":"Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice","volume":"28","author":"Henriques","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib71","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/HYPERTENSIONAHA.115.05654","article-title":"Androgen receptor promotes abdominal aortic aneurysm development via modulating inflammatory interleukin-1alpha and transforming growth factor-beta1 expression","volume":"66","author":"Huang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib72","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12020-018-1801-3","article-title":"Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment","volume":"63","author":"Zavatta","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2164-8-237","article-title":"Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms","volume":"8","author":"Lenk","year":"2007","journal-title":"BMC Genom."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jvs.2010.02.012","article-title":"An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance","volume":"52","author":"Thompson","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib75","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jss.2013.05.002","article-title":"Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model","volume":"185","author":"Kurobe","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib76","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/ATVBAHA.112.300820","article-title":"Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt","volume":"33","author":"Liu","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib77","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0706098","article-title":"Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms","volume":"144","author":"Cassis","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib78","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1111\/bph.13098","article-title":"Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-\/-) mice and angiogenesis","volume":"172","author":"Escudero","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib79","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1535-7163.MCT-05-0018","article-title":"The selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma","volume":"4","author":"Yen","year":"2005","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.HYP.35.1.297","article-title":"Downregulation of angiotensin II type 1 receptor by all-trans retinoic acid in vascular smooth muscle cells","volume":"35","author":"Takeda","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib81","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/labinvest.2016.55","article-title":"Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm","volume":"96","author":"Nieuwland","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib82","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1161\/ATVBAHA.116.307530","article-title":"Vitamin D receptor activation reduces angiotensin-II-induced dissecting abdominal aortic aneurysm in apolipoprotein E-knockout mice","volume":"36","author":"Martorell","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib83","first-page":"519","article-title":"Liver X receptor: a cardinal target for atherosclerosis and beyond","volume":"21","author":"Parikh","year":"2014","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1537-1891(02)00175-1","article-title":"LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis","volume":"38","author":"Edwards","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib85","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/jcp.2005.026161","article-title":"mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease","volume":"58","author":"Soumian","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib86","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1161\/01.STR.0000147036.07307.93","article-title":"ABCA1 expression in carotid atherosclerotic plaques","volume":"35","author":"Albrecht","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR\u03b1 and PPAR\u03b3 activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib88","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.acthis.2015.11.012","article-title":"Evidence of deregulated cholesterol efflux in abdominal aortic aneurysm","volume":"118","author":"Mourmoura","year":"2016","journal-title":"Acta Histochem."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib89","doi-asserted-by":"crossref","first-page":"34056","DOI":"10.1038\/srep34056","article-title":"NOR-1\/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress","volume":"6","author":"Alonso","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib90","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12872-017-0701-4","article-title":"Deletion of the NR4A nuclear receptor NOR1 in hematopoietic stem cells reduces inflammation but not abdominal aortic aneurysm formation","volume":"17","author":"Qing","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib91","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm1579","article-title":"Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia","volume":"13","author":"Mullican","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib92","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/ATVBAHA.110.206573","article-title":"Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?","volume":"30","author":"Golledge","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.02.009_bib93","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/febs.13634","article-title":"Atherosclerosis and aortic aneurysm - is inflammation a common denominator?","volume":"283","author":"Peshkova","year":"2016","journal-title":"FEBS J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020300897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020300897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:42:36Z","timestamp":1758156156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020300897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":93,"alternative-id":["S0021915020300897"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.02.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear receptors in abdominal aortic aneurysms","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}